BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33993248)

  • 1. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
    Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
    Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
    Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
    Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
    Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
    Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evaluation of pheochromocytoma and paraganglioma.
    Eisenhofer G; Peitzsch M
    Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
    Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals for deconjugated urine metanephrines by Bhattacharya analysis.
    Li B; King R; Sies C; Thompson S; Florkowski C
    Ann Clin Biochem; 2024 May; 61(3):173-181. PubMed ID: 37710976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
    Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
    Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
    Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.
    Smy L; Kushnir MM; Frank EL
    J Mass Spectrom Adv Clin Lab; 2021 Aug; 21():19-26. PubMed ID: 34820673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma.
    Lagerstedt SA; O'Kane DJ; Singh RJ
    Clin Chem; 2004 Mar; 50(3):603-11. PubMed ID: 14726465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.
    Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA
    Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
    Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
    Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.